Explore real-world examples of monoclonal antibody biosimilars like bevacizumab and rituximab. Learn how they differ from generics, their clinical uses in cancer and autoimmune diseases, and the safety data driving their adoption.
Explore real-world examples of monoclonal antibody biosimilars like bevacizumab and rituximab. Learn how they differ from generics, their clinical uses in cancer and autoimmune diseases, and the safety data driving their adoption.